A Trial for Peroperative Procedure and Postoperative Pain After Rectal Misoprostol or Rectal Hyoscine Administration
Hysteroscopic Surgery, Pain, Postoperative
About this trial
This is an interventional diagnostic trial for Hysteroscopic Surgery focused on measuring misoprostol, hyoscine butyl bromide, cervical dilatation, cervical ripening, hysteroscopy, pain
Eligibility Criteria
Inclusion Criteria:
- Reproductive aged women
- Women who are scheduled for hysteroscopy for indications of endometrial polyp, submucous myoma or synaechiae
Exclusion Criteria:
- Women who have undergone hysteroscopy previously
- women who are in menopause
Sites / Locations
- Bezmialem Vakif University
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
No Intervention
Rectal misoprostol
Rectal hyoscine butyl bromide
Sham administration
200 mcg of misoprostol will be administered rectally- 2 hours previously. This intervention will be performed by a third party health professional who will be blinded to the procedure.
10 mg hyoscine butyl bromide administered rectally- 2 hours previously. This intervention will be performed by a third party health professional who will be blinded to the procedure.
A rectal examination will be performed by a third party health professional who will be blinded to the procedure. No drug will be administered